Cleared Traditional

Afina (K181501) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K181501 · Neurovision Imaging, LLC · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
148d
Days
Class 2
Risk

K181501 is an FDA 510(k) clearance for the Afina. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Neurovision Imaging, LLC (Sacramento, US). The FDA issued a Cleared decision on November 2, 2018 after a review of 148 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurovision Imaging, LLC devices

Submission Details

510(k) Number K181501 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2018
Decision Date November 02, 2018
Days to Decision 148 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 110d · This submission: 148d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 51
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K181501.
Harmony Referral System with Harmony OCT Viewer (Octave)
K253893 · Topcon Healthcare Solutions EMEA Oy · Jun 2026
iCare ALTIUS CW
K234076 · Centervue S.P.A. · Aug 2024
IMAGEnet6 Ophthalmic Data System
K232828 · Topcon Corporation · Mar 2024
CALLISTO eye
K232944 · Carl Zeiss Meditec, AG · Dec 2023
Harmony
K232555 · Topcon Healthcare Solutions · Nov 2023
CALLISTO eye
K231676 · Carl Zeiss Meditec, AG · Aug 2023